The product of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide having a plasmin peptide substrate of 2-4 amino acids and mono- or di-peptide linkage, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by plasmin. Also disclosed are methods of making and using the prodrug compounds.

 
Web www.patentalert.com

< Polyamide-Polyether Block Copolymer

> Tamper resistant lipid-based oral dosage form for opioid agonists

> Active Ingredient-Containing Silicone Elastomers

~ 00504